Are you Dr. Bowne?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 86 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1100 Walnut St
Fl 5
Philadelphia, PA 19107Phone+1 215-955-6750Fax+1 215-923-8222
Summary
- Dr. Wilbur Bowne, MD is a general surgeon in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and New York. He is affiliated with Thomas Jefferson University Hospital, Hahnemann University Hospital, and Cancer Treatment Centers of America Philadelphia.
Education & Training
- Icahn School of Medicine at Mount SinaiResidency, Surgery, 1999 - 2002
- Boston University Medical CenterResidency, Surgery, 1994 - 1999
- State University of New York Downstate Medical Center College of MedicineClass of 1994
Certifications & Licensure
- NY State Medical License 1996 - 2026
- PA State Medical License 2010 - 2024
- NJ State Medical License 2011 - 2015
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 1 citationsAssociation of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.Timothy Chao, Zi-Xuan Wang, Wilbur B Bowne, Clifford J Yudkoff, Ava Torjani
Archives of Pathology & Laboratory Medicine. 2024-12-01 - Incisional hernia after major pancreatic resection: long term risk assessment from two distinct sources - A large multi-institutional network and a single high-volume ...Nitzan Zohar, Eliyahu Gorgov, Theresa P Yeo, Harish Lavu, Wilbur Bowne
HPB. 2024-12-01 - Pancreaticoduodenectomy after endoscopic ultrasound-guided lumen apposing metal stent (LAMS): A case series evaluating feasibility and short-term outcomes.Luke T Meredith, David Baek, Alisha Agarwal, Faisal Kamal, Anand R Kumar
Heliyon. 2024-09-15
Press Mentions
- Dressed to Kill: Tailoring a Suit for Tumor-Penetrating Cancer MedicationsApril 8th, 2016
Professional Memberships
- Member